• Company
  • Technology
  • Team
    • Board of Directors
    • Management
    • Extended Management
    • Project Management
  • Partners & Advisors
    • Preclinical Research
    • Clinical Research
    • Strategic Investment
  • Investors
  • News
    • Company News
    • Scientific Publications
  • Contact

Scientific Publications

Live-attenuated vaccines as a promising tool to defeat Covid-19

21 October 2022
contact@rocketvax.com +41 61 561 54 21

RocketVax AG

c/o Swiss Rockets AG

Rittergasse 3, 4051 Basel

Switzerland

Contact Us

Your Name*

Your Email*

Subject

Message

Privacy Policy Legal Disclaimer
© Copyright 2023. RocketVax AG. All rights reserved